NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free SOLV Stock Alerts $65.01 -0.90 (-1.37%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range$63.75▼$65.8650-Day Range N/A52-Week Range$60.72▼$96.05Volume2.11 million shsAverage Volume3.21 million shsMarket Capitalization$11.21 billionP/E RatioN/ADividend YieldN/APrice Target$69.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Get Solventum alerts: Email Address Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic About SolventumSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More SOLV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SOLV Stock News HeadlinesApril 4, 2024 | marketbeat.com3M Spun Off Its Health Division, Is It Still A Buy?Investors woke up this week to find shares of 3M NYSE: MMM trade lower by roughly 20%. What seemed to be a recovery is now a scary environment for 3M shareholders.April 30, 2024 | msn.com3M Non-GAAP EPS of $2.39 beats by $0.28, revenue of $7.7B beats by $40MApril 30, 2024 | Wall Street Star (Ad)AI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 29, 2024 | msn.com3M Earnings Are Almost Here. Expect Big Changes.April 25, 2024 | markets.businessinsider.comSolventum Corporation: Hold Rating Justified Amid Market Stability and Competitive ChallengesApril 24, 2024 | fool.comAlbemarle (NYSE: ALB)April 23, 2024 | prnewswire.comSolventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor EventsApril 16, 2024 | morningstar.comSolvac SA SOLVApril 30, 2024 | PharmaStocksToday (Ad)NYSE Spotlight & A Soaring Biotech Breakthrough You Need to SeeThe CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. April 16, 2024 | fool.comFigs (NYSE: FIGS)April 15, 2024 | prnewswire.comSolventum Names Shirley Edwards to Board of DirectorsApril 12, 2024 | barrons.comSolventum Stock Is Cheap. Why Wall Street Says to Wait.April 9, 2024 | finance.yahoo.comSolventum completes spin off from 3MApril 2, 2024 | msn.com3M health care spinoff becomes Minnesota's newest Fortune 500 companyApril 2, 2024 | bizjournals.com3M stock jumps after Solventum spinoff completion, PFAS settlementApril 2, 2024 | finance.yahoo.comSolventum Begins Trading on the New York Stock ExchangeApril 1, 2024 | investorplace.com3M Finalizes Drinking Water Settlement Amidst Solventum SpinoffApril 1, 2024 | seekingalpha.comSolventum: Thoughts On The 3M Healthcare SpinoffSee More Headlines Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/30/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:SOLV Previous Symbol: CUSIPN/A CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$69.50 High Stock Price Target$70.00 Low Stock Price Target$69.00 Potential Upside/Downside+5.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.47Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares172,510,000Free FloatN/AMarket Cap$11.37 billion OptionableOptionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Bryan C. Hanson (Age 57)CEO & Director Mary T. WilcoxChief Accounting OfficerMs. Amy LanducciChief Information & Digital OfficerMr. Paul S. HarringtonChief Supply Chain OfficerMichael J. OttesenVice PresidentKey CompetitorsInsuletNASDAQ:PODDTeleflexNYSE:TFXPenumbraNYSE:PENInspire Medical SystemsNYSE:INSPGlobus MedicalNYSE:GMEDView All Competitors SOLV Stock Analysis - Frequently Asked Questions Should I buy or sell Solventum stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Solventum in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SOLV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SOLV, but not buy additional shares or sell existing shares. View SOLV analyst ratings or view top-rated stocks. What is Solventum's stock price target for 2024? 3 Wall Street research analysts have issued 12 month price objectives for Solventum's shares. Their SOLV share price targets range from $69.00 to $70.00. On average, they anticipate the company's share price to reach $69.50 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View analysts price targets for SOLV or view top-rated stocks among Wall Street analysts. How have SOLV shares performed in 2024? Solventum's stock was trading at $66.90 at the beginning of 2024. Since then, SOLV shares have decreased by 2.8% and is now trading at $65.01. View the best growth stocks for 2024 here. When is Solventum's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our SOLV earnings forecast. What ETFs hold Solventum's stock? ETFs with the largest weight of Solventum (NYSE:SOLV) stock in their portfolio include Leatherback Long/Short Alternative Yield ETF (LBAY), ProShares Smart Materials ETF (TINT) and Pacer BioThreat Strategy ETF (VIRS).Global X Dow 30 Covered Call ETF (DJIA). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SOLV) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTITrump’s last act as President Porter & CompanyJeff Bezos Just Humiliated Elon MuskInvestorPlaceElon Musk Secret Crypto Plot ExposedCrypto 101 MediaREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
